Products Affected - Description
Cytra-K Crystals, Cypress Pharmaceuticals
Citric acid 1,002 mg/ potassium citrate 3,300 mg per packet (NDC 60258-0005-01)
Cytra-K solution, Cypress Pharmaceuticals
Citric acid 334 mg/ potassiumcitrate 1,100 mg per 5 mL solution (NDC 60258-0003-16)
Reason for the Shortage
Cypress Pharmaceuticals has Cytra-K crystals and solution on back order because the product is being relabeled.
No presentations are available.
Estimated Resupply Dates
Cypress Pharmaceuticals has Cytra-K crystals and solution on back order and the company cannot estimate a release date.
January 9, 2015; November 26, 2014; October 8, 2014; September 8, 2014; July 14, 2014; May 7, 2014; March 17, 2014; February 13, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins